Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- Navamedic Establishes Chitin Production in Northern Norway
Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry.
- PepsiAmericas Buys Ardea Beverage Co.
Company has purchased Ardea Beverage Co., maker of airforce Nutrisoda.
- PepsiAmericas Buys Ardea Beverage Co.
Company has purchased Ardea Beverage Co., maker of airforce Nutrisoda.
- Herbalife Opens for Business in Malaysia
Malayia becomes 61st country where Herbalife products are sold through the company's network of independent distributors; Dato' Ronie Tan has been named managing director and vice president of Herbalife in Malaysia.
- Herbalife Opens for Business in Malaysia
Malayia becomes 61st country where Herbalife products are sold through the company's network of independent distributors; Dato' Ronie Tan has been named managing director and vice president of Herbalife in Malaysia.
- Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients
Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients.
- Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients
Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients.
- Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients
Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients.
- Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients
Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients.
- Biogaia Signs Agreement With Novartis Consumer Health SA
BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies.
- Biogaia Signs Agreement With Novartis Consumer Health SA
BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies.
- Biogaia Signs Agreement With Novartis Consumer Health SA
BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies.
- Biogaia Signs Agreement With Novartis Consumer Health SA
BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies.
- Cyanotech CEO Reports on Business Development Trip to Asia
Company announces that distribution agreements have been signed with a Chinese-American joint venture that the company believes will generate orders for BioAstin and NatuRose in 2006.
- Cyanotech CEO Reports on Business Development Trip to Asia
Company announces that distribution agreements have been signed with a Chinese-American joint venture that the company believes will generate orders for BioAstin and NatuRose in 2006.
- Cyanotech Corporation Announces Resignation of Jeffrey H. Sakamoto, Chief Financial Officer
Company announces that Jeffrey H. Sakamoto has resigned as Chief Financial Officer of the Company effective November 25, 2005.
- Cyanotech Corporation Announces Resignation of Jeffrey H. Sakamoto, Chief Financial Officer
Company announces that Jeffrey H. Sakamoto has resigned as Chief Financial Officer of the Company effective November 25, 2005.
- Cyanotech Corporation Announces Resignation of Jeffrey H. Sakamoto, Chief Financial Officer
Company announces that Jeffrey H. Sakamoto has resigned as Chief Financial Officer of the Company effective November 25, 2005.
- Cyanotech Corporation Announces Resignation of Jeffrey H. Sakamoto, Chief Financial Officer
Company announces that Jeffrey H. Sakamoto has resigned as Chief Financial Officer of the Company effective November 25, 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales of $36.7 million compared to $35.3 million for the same quarter of fiscal 2005, with net income of $3.5 million, or $0.30 diluted earnings per share, compared to $2.8 million, or $0.24 diluted earnings per share, for the same quarter of fiscal 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales of $36.7 million compared to $35.3 million for the same quarter of fiscal 2005, with net income of $3.5 million, or $0.30 diluted earnings per share, compared to $2.8 million, or $0.24 diluted earnings per share, for the same quarter of fiscal 2005.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Lipid Nutrition Acquires PharmaNutrients’ CLA One Business
Lipid Nutrition has signed an agreement to acquire PharmaNutrients’ CLA One® business effective February 1, 2006.
- Neptune Technologies & Bioressources Inc. Reports Second Quarter Results
Company reports operating revenues of $1,445,000 compared to $1,180,000, for the second quarter in 2005, with EBITDA increasing to $245,000 compared to $119,000 prior year.
- Neptune Technologies & Bioressources Inc. Reports Second Quarter Results
Company reports operating revenues of $1,445,000 compared to $1,180,000, for the second quarter in 2005, with EBITDA increasing to $245,000 compared to $119,000 prior year.
- NBTY Reports First Quarter Results
Company reports that net sales increased $35 million, or 8%, to $455 million (including $33 million in net sales due to the acquisition of Solgar, LeNaturiste and SISU) compared to sales of $420 million prior year, as net income was $23 million, or $0.33 per diluted share, compared to $30 million, or $0.43 per diluted share, for the fiscal first quarter ended December 31, 2004.
- NBTY Reports First Quarter Results
Company reports that net sales increased $35 million, or 8%, to $455 million (including $33 million in net sales due to the acquisition of Solgar, LeNaturiste and SISU) compared to sales of $420 million prior year, as net income was $23 million, or $0.33 per diluted share, compared to $30 million, or $0.43 per diluted share, for the fiscal first quarter ended December 31, 2004.
- AMS Health Sciences, Inc. Announces Appointment of New President
Company announces the appointment of Jerry W. Grizzle, PhD, as the Company President.
- AMS Health Sciences, Inc. Announces Appointment of New President
Company announces the appointment of Jerry W. Grizzle, PhD, as the Company President.
- AMS Health Sciences, Inc. Announces Appointment of New President
Company announces the appointment of Jerry W. Grizzle, PhD, as the Company President.
- AMS Health Sciences, Inc. Announces Appointment of New President
Company announces the appointment of Jerry W. Grizzle, PhD, as the Company President.
- United Natural Foods, Inc. Names Randle E. Lindberg President of the Western Region
Company has appointed Randle E. "Randy" Lindberg, the former President and Chief Executive Officer of Nature's Best, to the position of President of the Western Region.
- United Natural Foods, Inc. Names Randle E. Lindberg President of the Western Region
Company has appointed Randle E. "Randy" Lindberg, the former President and Chief Executive Officer of Nature's Best, to the position of President of the Western Region.
- United Natural Foods, Inc. Names Randle E. Lindberg President of the Western Region
Company has appointed Randle E. "Randy" Lindberg, the former President and Chief Executive Officer of Nature's Best, to the position of President of the Western Region.
- United Natural Foods, Inc. Names Randle E. Lindberg President of the Western Region
Company has appointed Randle E. "Randy" Lindberg, the former President and Chief Executive Officer of Nature's Best, to the position of President of the Western Region.
- Leiner Health Products Reports Third Quarter 2006 Results
Company reports net sales of $181.2 million compared to $189.3 million for the same period in fiscal 2005 with net income of $1.5 million for the quarter, compared to net income of $8.1 million for the same quarter prior year. Company notes improvement over the first two quarters resulted from stabilization of joint care margins on lower raw material costs and better fixed cost absorption from better plant throughput.
- Leiner Health Products Reports Third Quarter 2006 Results
Company reports net sales of $181.2 million compared to $189.3 million for the same period in fiscal 2005 with net income of $1.5 million for the quarter, compared to net income of $8.1 million for the same quarter prior year. Company notes improvement over the first two quarters resulted from stabilization of joint care margins on lower raw material costs and better fixed cost absorption from better plant throughput.
- Stagnito Communications, FMI Announce Marketing Agreement
Stagnito Communications Inc. announces a marketing agreement with the Food Marketing Institute in which it will produce a custom magazine for the Private Label Pavilion at the FMI Show, May 7-9 in Chicago.
- Stagnito Communications, FMI Announce Marketing Agreement
Stagnito Communications Inc. announces a marketing agreement with the Food Marketing Institute in which it will produce a custom magazine for the Private Label Pavilion at the FMI Show, May 7-9 in Chicago.
- Stagnito Communications, FMI Announce Marketing Agreement
Stagnito Communications Inc. announces a marketing agreement with the Food Marketing Institute in which it will produce a custom magazine for the Private Label Pavilion at the FMI Show, May 7-9 in Chicago.
- Stagnito Communications, FMI Announce Marketing Agreement
Stagnito Communications Inc. announces a marketing agreement with the Food Marketing Institute in which it will produce a custom magazine for the Private Label Pavilion at the FMI Show, May 7-9 in Chicago.
- One World Nutrition Completes Private Placement Offering
One World Nutrition Inc. announced the closing of its initial private placement offering, after raising $3 million at $1.50 per share of common stock sold.
- One World Nutrition Completes Private Placement Offering
One World Nutrition Inc. announced the closing of its initial private placement offering, after raising $3 million at $1.50 per share of common stock sold.
- Atkins Nutritionals, Inc. Announces New Board of Directors
Robert W. Carpenter, president of ARAMARK Healthcare - Food, Kevin S. Flannery, president and CEO of Whelan Financial Corporation, Tim Healy, former chairman and CEO of Ubiquity Brands, Inc and Hugh R. Rovit, principal in interim management at Masson & Company LLC join President Mark S. Rodriguez on the Board of Directors.
- Atkins Nutritionals, Inc. Announces New Board of Directors
Robert W. Carpenter, president of ARAMARK Healthcare - Food, Kevin S. Flannery, president and CEO of Whelan Financial Corporation, Tim Healy, former chairman and CEO of Ubiquity Brands, Inc and Hugh R. Rovit, principal in interim management at Masson & Company LLC join President Mark S. Rodriguez on the Board of Directors.
- Atkins Nutritionals, Inc. Announces New Board of Directors
Robert W. Carpenter, president of ARAMARK Healthcare - Food, Kevin S. Flannery, president and CEO of Whelan Financial Corporation, Tim Healy, former chairman and CEO of Ubiquity Brands, Inc and Hugh R. Rovit, principal in interim management at Masson & Company LLC join President Mark S. Rodriguez on the Board of Directors.
- Atkins Nutritionals, Inc. Announces New Board of Directors
Robert W. Carpenter, president of ARAMARK Healthcare - Food, Kevin S. Flannery, president and CEO of Whelan Financial Corporation, Tim Healy, former chairman and CEO of Ubiquity Brands, Inc and Hugh R. Rovit, principal in interim management at Masson & Company LLC join President Mark S. Rodriguez on the Board of Directors.
- The Hain Celestial Group Announces Sales and Earnings
Company reports quarterly sales of $186.2 million, a 10% increase over the prior year's $169.8 million, with net income of $12.7 million, compared to the prior year's $10.7 million.
- The Hain Celestial Group Announces Sales and Earnings
Company reports quarterly sales of $186.2 million, a 10% increase over the prior year's $169.8 million, with net income of $12.7 million, compared to the prior year's $10.7 million.
- Nutrition 21 Retains Dresdner Kleinwort Wasserstein
Company announces that it has retained the investment banking firm Dresdner Kleinwort Wasserstein to assist the company in evaluating possible strategic alternatives.
- Nutrition 21 Retains Dresdner Kleinwort Wasserstein
Company announces that it has retained the investment banking firm Dresdner Kleinwort Wasserstein to assist the company in evaluating possible strategic alternatives.
- PacificHealth Laboratories Announces Receipt of Patent for Their Accelerade(R) Sports Drink
Company announces that the U. S. Patent and Trademark Office issued patent number US 6,989,171 for the use of carbohydrate and protein in combination for a sports drink.
- PacificHealth Laboratories Announces Receipt of Patent for Their Accelerade(R) Sports Drink
Company announces that the U. S. Patent and Trademark Office issued patent number US 6,989,171 for the use of carbohydrate and protein in combination for a sports drink.
- PacificHealth Laboratories Announces Receipt of Patent for Their Accelerade(R) Sports Drink
Company announces that the U. S. Patent and Trademark Office issued patent number US 6,989,171 for the use of carbohydrate and protein in combination for a sports drink.
- PacificHealth Laboratories Announces Receipt of Patent for Their Accelerade(R) Sports Drink
Company announces that the U. S. Patent and Trademark Office issued patent number US 6,989,171 for the use of carbohydrate and protein in combination for a sports drink.
- CV Technologies Conditionally Approved for Listing on the TSX
CV Technologies will begin trading on the TSX under its current symbol, CVQ, at a date yet to be determined.
- CV Technologies Conditionally Approved for Listing on the TSX
CV Technologies will begin trading on the TSX under its current symbol, CVQ, at a date yet to be determined.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- MidOcean Partners Agrees to Sell Majority Stake in Vitaquest International to CK Life Sciences
MidOcean Partners has announced the signing of a definitive agreement to sell its majority stake in Vitaquest to an affiliate of CK Life Sciences Int'l., Inc., in a transaction that values Vitaquest at a total enterprise value of $345 million.
- Degussa Veteran to Lead Global Food Strategy at The Solae Company
The Solae Company has announced that Thomas Damiano would lead the organization's global food platform strategy, resigning his position as Vice President of Commercial Development at Degussa AG's food ingredient business.
- Degussa Veteran to Lead Global Food Strategy at The Solae Company
The Solae Company has announced that Thomas Damiano would lead the organization's global food platform strategy, resigning his position as Vice President of Commercial Development at Degussa AG's food ingredient business.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
- EPAX Sister Company Austral Group Wins National Peruvian Award For Responsible Environmental Management
Austral Group, a sister company of EPAX AS, has won the Fourth National Peruvian Responsible Management contest in the award category of Cleanest, Most Eco-Efficient Production. The recognition is largely a result of the company's Environmental Management System Model, an impact-reducing production method successfully implemented in all its plants.
|
LONG BEACH, Calif., January 27, 2006 - The Zuellig Group (ZG) today announced the appointment of George M. Pontiakos to President and CEO of Zuellig Group North America. He will oversee all aspects of North American operations including BI Nutraceuticals, Premium Performance Ingredients, AF Zeta and the Zuellig Group Nutrition and Ingredients, China.
"George has extensive experience across a diverse range of industries, and has been successful in building the companies he manages into world leaders in their respective markets," stated Bill Meaney, CEO, The Zuellig Group. "We are very pleased to have him join our team and feel that his strong and decisive leadership will have a tremendous positive impact on the company."
Pontiakos has held senior leadership positions at several leading consulting, medical services and technology companies including Monovasia, which he founded, Oluma, Lucent, Agere, Ortel, NetVantage and Timeplex. He has wide-ranging experience in scaling geographically dispersed global companies to maximize their ability to successfully compete in the marketplace. Pontiakos holds a Bachelor of Science degree in Business Management from Farleigh Dickinson University, New Jersey.
Zuellig Group Nutrition and Ingredients (ZGNI) is a leading manufacturer, marketer and distributor of value-added, premium quality, dietary supplement and food ingredients. The entities within the group include BI Nutraceuticals, Long Beach, CA, Premium Performance Ingredients, Islandia, NY and ZGNI China, Shanghai, China. ZGNI services the nutrition, food and healthcare industries worldwide.
# # # |